Bilimsel çalışmalar

Dr. Öğr. Ü. Mert Öztaş

22 yayın. Her yayının yanında bilginin kaynağı yazar.

Profile dön
  1. Impact of SAA versus CRP in evaluation of acute-phase response in familial Mediterranean fever

    Medicine, 2026

    DOI 10.1097/md.0000000000050309 PMID 42629676 Açık erişimli tam metinKaynak: OpenAlex

  2. Musculoskeletal Manifestations in Behçet’s Syndrome

    Springer eBooks, 2025

    DOI 10.1007/978-3-031-77251-1_14 Kaynak: OpenAlex

  3. Rituximab in the management of retroperitoneal fibrosis: A single tertiary rheumatology care center experience

    International Journal of Rheumatic Diseases, 2023

    DOI 10.1111/1756-185x.14798 PMID 37358327 2 atıf (Europe PMC) Kaynak: OpenAlex

  4. Frequency and severity of COVID‐19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine

    Journal of Medical Virology, 2022

    DOI 10.1002/jmv.27731 PMID 35315100 5 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  5. Antibody responses to inactivated and mRNA SARS-CoV-2 vaccines in familial Mediterranean fever patients treated with interleukin-1 inhibitors

    Rheumatology, 2022

    DOI 10.1093/rheumatology/keac123 PMID 35258567 3 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  6. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-04841-3 PMID 33779780 82 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  7. Antibody response to inactivated COVID-19 vaccine (CoronaVac) in immune-mediated diseases: a controlled study among hospital workers and elderly

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-04910-7 PMID 34109466 68 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  8. The incidence, clinical characteristics, and outcome of COVID-19 in a prospectively followed cohort of patients with Behçet’s syndrome

    Rheumatology International, 2021

    DOI 10.1007/s00296-021-05056-2 PMID 34825278 8 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  9. Presentation characteristics and clinical outcome of patients with giant cell arteritis followed by a single center

    TURKISH JOURNAL OF MEDICAL SCIENCES, 2021

    DOI 10.3906/sag-2102-263 PMID 36326373 2 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  10. Efficacy and Safety of Imatinib Treatment in Elderly Patients With Chronic Myeloid Leukemia: Real-Life Data and a Single-Center Experience

    Clinical Lymphoma Myeloma & Leukemia, 2021

    DOI 10.1016/j.clml.2021.04.005 PMID 34052176 6 atıf (Europe PMC) Kaynak: OpenAlex

  11. Haemophagocytic lymphohistiocytosis in a patient with familial Mediterranean fever and miliary tuberculosis: a case report

    Modern Rheumatology Case Reports, 2021

    DOI 10.1093/mrcr/rxab026 PMID 34549298 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  12. Changing the traditional p-value significance threshold to .005 does not decrease the number of statistically significant p-values in observational studies more than in randomised controlled trials

    Clinical and Experimental Rheumatology, 2021

    DOI 10.55563/clinexprheumatol/smg1bu PMID 33253087 Kaynak: OpenAlex

  13. Concerns Regarding the Analysis of a Takayasu Arteritis Cohort: Comment on the Article by Goel et al

    Arthritis & Rheumatology, 2021

    DOI 10.1002/art.41784 PMID 33982898 Kaynak: OpenAlex

  14. Characteristics and outcomes of Behçet’s syndrome patients with Coronavirus Disease 2019: a case series of 10 patients

    Internal and Emergency Medicine, 2020

    DOI 10.1007/s11739-020-02427-8 PMID 32647946 19 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  15. Giant Cell Arteritis with Concomitant Chronic Myelomonocytic Leukemia

    Turkish Journal of Hematology, 2020

    DOI 10.4274/tjh.galenos.2020.2020.0357 PMID 32702949 1 atıf (Europe PMC) Açık erişimli tam metinKaynak: OpenAlex

  16. A Rare Cause of AA Amyloidosis

    JCR Journal of Clinical Rheumatology, 2020

    DOI 10.1097/rhu.0000000000001613 PMID 33298821 Kaynak: OpenAlex

  17. Evaluation of the follow-up and drug-related side effects of bosentan treatment for the treatment of systemic sclerosis related digital ulcer: a real life experience

    Ulusal Romatoloji Dergisi, 2020

    DOI 10.4274/raed.galenos.2020.97269 Kaynak: OpenAlex

  18. AB1097 RETROPERITONEAL FIBROSIS- A SINGLE CENTER EXPERIENCE

    Annals of the Rheumatic Diseases, 2019

    DOI 10.1136/annrheumdis-2019-eular.7266 Kaynak: OpenAlex

  19. Atorvastatin-induced dermatomyositis

    Rheumatology International, 2017

    DOI 10.1007/s00296-017-3658-9 PMID 28238074 12 atıf (Europe PMC) Kaynak: OpenAlex

  20. Real-Life Data and a Single Center Experience on the Efficacy and Toxicity Profile of Imatinib in the Treatment of Elderly Patients with Chronic Myeloid Leukemia

    Blood, 2016

    DOI 10.1182/blood.v128.22.1905.1905 Kaynak: OpenAlex

  21. Frequency and severity of COVID-19 in patients with various rheumatic diseases treated regularly with colchicine or hydroxychloroquine.

    Kaynak: acibadem.com.tr profil sayfası

  22. Atorvastatin-induced dermatomyositis.

    Kaynak: acibadem.com.tr profil sayfası